• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足月妊娠中母胎胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 的参考范围:一项前瞻性观察研究。

Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.

机构信息

Division of Obstetrics and Gynaecology, Oslo University Hospital Ullevål, Oslo, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

PLoS One. 2020 Oct 20;15(10):e0240473. doi: 10.1371/journal.pone.0240473. eCollection 2020.

DOI:10.1371/journal.pone.0240473
PMID:33079955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7575115/
Abstract

BACKGROUND

Post-term pregnancies have increased risks for adverse fetal and maternal outcomes. Maternal concentrations of the placenta-associated proteins placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) have been identified as predictors for preeclampsia and fetal growth restriction, both syndromes of placental dysfunction. We have proposed that low maternal circulating PlGF and increased sFlt-1 are general markers for syncytiotrophoblast stress, which increases at and beyond term, even in apparently uncomplicated pregnancies. Our aim was to establish circulating PlGF, sFlt-1, and sFlt-1/PlGF reference ranges in healthy post-term pregnancies (gestational week ≥40+2), comparing with healthy term pregnancies and evaluating associations between time to delivery and biomarker percentiles.

METHODS

Of 501 healthy, singleton post-term pregnancies prospectively recruited between September 2016 and December 2017 at our tertiary obstetric department, 426 with an uncomplicated delivery outcome contributed PlGF and sFlt-1 serum concentrations for reference range construction. A retrospective, cross-sectional, term group with an uncomplicated delivery outcome (n = 146) served as comparison. Differences in percentile values between groups and confidence intervals were calculated by quantile regression.

RESULTS

In post-term pregnancies the 5th, 50th, and 95th percentiles for PlGF were: 70, 172, and 496 pg/mL; for sFlt-1: 2074, 4268, and 9141 pg/mL; and for sFlt-1/PlGF 5.3, 25.5, and 85.2. Quantile regression analyses comparing the post-term to the term group showed for PlGF a trend towards higher 10th through 30th percentiles, for sFlt-1 significantly higher 10th through 80th percentiles, and for sFlt-1/PlGF ratio significantly higher 30th percentile and significantly lower 95th percentile. PlGF below the 5th percentile and sFlt-1/PlGF ratio above the 95th percentile was associated with shorter time to delivery (p = 0.031 and p = 0.025, respectively).

CONCLUSIONS

Our findings support the concept of increasing syncytiotrophoblast stress post-term in clinically healthy pregnancies. Whether post-term dysregulated angiogenic markers reflect a biological placental clock merits further investigation.

摘要

背景

过期妊娠会增加胎儿和母体不良结局的风险。胎盘相关蛋白胎盘生长因子(PlGF)和可溶性 fms 样酪氨酸激酶-1(sFlt-1)的母体浓度已被确定为先兆子痫和胎儿生长受限的预测因子,这两种综合征均为胎盘功能障碍。我们提出,低母体循环 PlGF 和增加的 sFlt-1 是合体滋养层应激的一般标志物,这种应激在足月时甚至在看似正常的妊娠中都会增加。我们的目的是建立健康过期妊娠(妊娠周≥40+2)的循环 PlGF、sFlt-1 和 sFlt-1/PlGF 参考范围,与健康足月妊娠进行比较,并评估到达分娩时间与生物标志物百分位数之间的关系。

方法

在我们的三级产科部门于 2016 年 9 月至 2017 年 12 月期间前瞻性招募的 501 例健康、单胎过期妊娠中,426 例分娩结局无并发症的产妇提供了 PlGF 和 sFlt-1 血清浓度以构建参考范围。一个具有无并发症分娩结局的回顾性、横截面、足月组(n=146)作为比较。通过分位数回归计算组间百分位数值的差异和置信区间。

结果

在过期妊娠中,PlGF 的第 5、50 和 95 百分位数分别为:70、172 和 496 pg/mL;sFlt-1:2074、4268 和 9141 pg/mL;sFlt-1/PlGF 为 5.3、25.5 和 85.2。将过期妊娠组与足月组进行比较的分位数回归分析显示,PlGF 的第 10 至 30 百分位有升高趋势,sFlt-1 的第 10 至 80 百分位明显升高,sFlt-1/PlGF 比值的第 30 百分位明显升高,第 95 百分位明显降低。PlGF 低于第 5 百分位数和 sFlt-1/PlGF 比值高于第 95 百分位数与分娩时间缩短有关(p=0.031 和 p=0.025)。

结论

我们的发现支持在临床健康妊娠中,足月后合体滋养层应激增加的概念。过期妊娠时失调的血管生成标志物是否反映了胎盘的生物时钟,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/212d/7575115/7d450a4bbc8e/pone.0240473.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/212d/7575115/ccf8a9a7f43b/pone.0240473.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/212d/7575115/7d450a4bbc8e/pone.0240473.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/212d/7575115/ccf8a9a7f43b/pone.0240473.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/212d/7575115/7d450a4bbc8e/pone.0240473.g002.jpg

相似文献

1
Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.足月妊娠中母胎胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 的参考范围:一项前瞻性观察研究。
PLoS One. 2020 Oct 20;15(10):e0240473. doi: 10.1371/journal.pone.0240473. eCollection 2020.
2
The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.健康过期妊娠中胎盘相关循环生物标志物与可能由胎盘原因引起的复合不良分娩结局之间的关联。
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1893-1901. doi: 10.1111/aogs.14223. Epub 2021 Jul 20.
3
Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.可溶性 fms 样酪氨酸激酶与胎盘生长因子比值在不同时期的胎儿生长受限及小于胎龄儿中的变化。
Acta Obstet Gynecol Scand. 2021 Jan;100(1):119-128. doi: 10.1111/aogs.13978. Epub 2020 Sep 14.
4
Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies.在正常血压的足月妊娠中,胎盘功能的标志物与母体外周血中有核胎儿细胞的存在率和数量相关。
Acta Obstet Gynecol Scand. 2023 Jun;102(6):690-698. doi: 10.1111/aogs.14547. Epub 2023 Mar 18.
5
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.新型循环胎盘标志物促动力蛋白-1、可溶性fms样酪氨酸激酶-1、可溶性内皮糖蛋白和胎盘生长因子及其与晚期流产的关联
Hum Reprod. 2016 Dec;31(12):2681-2688. doi: 10.1093/humrep/dew225. Epub 2016 Sep 22.
6
Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 可作为预测子痫前期的有用标志物,但不能作为预测小于胎龄儿的标志物:一项纵向研究。
Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):225-30. doi: 10.1016/j.ejogrb.2013.08.040. Epub 2013 Sep 4.
7
The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.可溶性血管内皮生长因子受体-1/胎盘生长因子比值对双胎妊娠短期子痫前期及母胎或新生儿并发症发生情况的预测价值。
Pregnancy Hypertens. 2018 Oct;14:222-227. doi: 10.1016/j.preghy.2018.03.014. Epub 2018 Mar 26.
8
Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.正常血压孕妇妊娠10至40周时循环可溶性fms样酪氨酸激酶-1和胎盘生长因子的情况。
J Perinat Med. 2017 Oct 26;45(7):895-901. doi: 10.1515/jpm-2017-0093.
9
Gestational Age-Specific Reference Ranges for the sFlt-1/PlGF Immunoassay Ratio in Twin Pregnancies.双胎妊娠 sFlt-1/PlGF 免疫分析法比值的胎龄特异性参考范围。
Fetal Diagn Ther. 2021;48(4):288-296. doi: 10.1159/000514378. Epub 2021 Mar 30.
10
Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.孕晚期正常妊娠孕妇血清血管生成因子水平:参考范围、母体及妊娠因素的影响以及胎儿胎盘多普勒指数
Fetal Diagn Ther. 2014;36(1):38-43. doi: 10.1159/000360078. Epub 2014 May 27.

引用本文的文献

1
Emerging modalities for neuroprognostication in neonatal encephalopathy: harnessing the potential of artificial intelligence.新生儿脑病神经预后评估的新兴模式:挖掘人工智能的潜力
Pediatr Res. 2025 Aug 19. doi: 10.1038/s41390-025-04336-y.
2
Microchimerism and pregnancy complications with placental dysfunction.微嵌合体与伴有胎盘功能障碍的妊娠并发症
Semin Immunopathol. 2025 Mar 11;47(1):21. doi: 10.1007/s00281-025-01045-w.
3
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation.(造血干细胞)移植中母胎微嵌合体的临床相关性。

本文引用的文献

1
Reference centiles for maternal placental growth factor levels at term from a low-risk population.足月低危人群胎盘生长因子水平的参考百分位数。
Placenta. 2019 Oct;86:15-19. doi: 10.1016/j.placenta.2019.08.086. Epub 2019 Aug 25.
2
Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.应用可溶性血管内皮生长因子受体-1/胎盘生长因子比值识别子痫前期和胎儿生长受限的临床实践:一项前瞻性队列研究。
Pregnancy Hypertens. 2018 Jul;13:279-285. doi: 10.1016/j.preghy.2018.06.017. Epub 2018 Jun 30.
3
Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Semin Immunopathol. 2024 Dec 7;47(1):4. doi: 10.1007/s00281-024-01028-3.
4
Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies.在正常血压的足月妊娠中,胎盘功能的标志物与母体外周血中有核胎儿细胞的存在率和数量相关。
Acta Obstet Gynecol Scand. 2023 Jun;102(6):690-698. doi: 10.1111/aogs.14547. Epub 2023 Mar 18.
5
Predelivery placenta-associated biomarkers and computerized intrapartum fetal heart rate patterns.分娩前胎盘相关生物标志物与计算机化产时胎儿心率模式。
AJOG Glob Rep. 2022 Dec 16;3(1):100149. doi: 10.1016/j.xagr.2022.100149. eCollection 2023 Feb.
6
New Markers for Placental Dysfunction at Term - Potential for More.足月胎盘功能障碍的新标志物——更多可能性
Geburtshilfe Frauenheilkd. 2022 Jul 7;82(7):719-726. doi: 10.1055/a-1761-1337. eCollection 2022 Jul.
可溶性 fms 样酪氨酸激酶-1 与胎盘生长因子比值:排除子痫前期可达 4 周,以及重复检测的价值。
Ultrasound Obstet Gynecol. 2019 Mar;53(3):367-375. doi: 10.1002/uog.19178. Epub 2019 Feb 4.
4
Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.妊娠期高血压疾病:国际实践的国际妊娠高血压研究学会分类、诊断及管理建议
Hypertension. 2018 Jul;72(1):24-43. doi: 10.1161/HYPERTENSIONAHA.117.10803.
5
Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes.晚期妊娠孕妇胎盘生长因子水平作为产时及围产期不良结局预测指标的系统评价
Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:26-34. doi: 10.1016/j.ejogrb.2018.03.059. Epub 2018 Mar 30.
6
Screening Performance of Placental Growth Factor for the Prediction of Low Birth Weight and Adverse Intrapartum and Neonatal Outcomes in a Term Low-Risk Population.胎盘生长因子对足月低风险人群低出生体重及产时和新生儿不良结局预测的筛查效能
Fetal Diagn Ther. 2018;44(3):194-201. doi: 10.1159/000480381. Epub 2017 Oct 11.
7
Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.早发型胎儿生长受限无症状女性中高可溶性fms样酪氨酸激酶-1与胎盘生长因子比值与不良结局的关联
Hypertens Pregnancy. 2017 Aug;36(3):269-275. doi: 10.1080/10641955.2017.1334800. Epub 2017 Jul 24.
8
Evidence that fetal death is associated with placental aging.有证据表明胎儿死亡与胎盘老化有关。
Am J Obstet Gynecol. 2017 Oct;217(4):441.e1-441.e14. doi: 10.1016/j.ajog.2017.06.015. Epub 2017 Jun 20.
9
The role of cellular senescence in ageing of the placenta.细胞衰老在胎盘老化中的作用。
Placenta. 2017 Apr;52:139-145. doi: 10.1016/j.placenta.2017.01.116. Epub 2017 Jan 16.
10
Review: Placental derived biomarkers of pregnancy disorders.综述:妊娠疾病的胎盘源性生物标志物
Placenta. 2017 Jun;54:104-110. doi: 10.1016/j.placenta.2017.01.119. Epub 2017 Jan 16.